Pfizer: Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter AndNine Months Ended December 31 2025.

Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 which were approved by the Board of Directors of the Company at their Meeting held today i.e. February 9 2026 that commenced at 3.00 p.m. and concluded at 4.45 p.m.